Study finds novel mechanism of action for NK cells in checkpoint inhibitor for cancer
PD-L1 checkpoint inhibitors are a powerful and growing form of immunotherapy used to treat melanoma, kidney cancer, head and neck cancers, Hodgkin's lymphoma and other cancers. The PD-L1 protein is expressed on tumor cells ...
Jul 26, 2019
1
128